World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
55
Citations
10477
World Ranking
15096
National Ranking
6315

Overview

Robert I. Glazer is affiliated with Georgetown University Medical Center in the United States. Their research primarily focuses on medicine, with significant contributions to immunology and microbiology. The main subfields of their work include oncology, immunology, epidemiology, obstetrics and gynecology, and public health.

Their recent publications cover various aspects of cancer biology, immunotherapy, and pregnancy-related medical research. Key topics addressed in their studies include cancer immunotherapy and biomarkers, immunotherapy and immune responses, preterm birth and chorioamnionitis, pregnancy and preeclampsia studies, cancer cells and metastasis, pregnancy-related medical research, and immune cells in cancer.

Frequent coauthors collaborating with Robert I. Glazer include Hongyan Yuan, Suman Ranjit, Michail Spiliopoulos, Andrew Haddad, and Huda B. Al-Kouatly.

Notable recent papers include:

  • Reduction of fibrosis and immune suppressive cells in ErbB2-dependent tumorigenesis by an LXR agonist, 2021, PLoS ONE
  • MicroRNA analysis in maternal blood of pregnancies with preterm premature rupture of membranes reveals a distinct expression profile, 2022, PLoS ONE
  • Resistance of MMTV-NeuT/ATTAC mice to anti-PD-1 immune checkpoint therapy is associated with macrophage infiltration and Wnt pathway expression, 2022, Oncotarget
  • 3D-Printed Tissue Models: Engineering a Novel 3D Printed Vascularized Tissue Model for Investigating Breast Cancer Metastasis to Bone, 2020, Advanced Healthcare Materials
  • Abstract 394: LXR agonist N,N-dimethyl-3-β-hydroxy-cholenamide, DMHCA, reduces ErbB2-dependent tumorigenesis and immune tolerance in a conditional model of mammary fibrosis, 2020, Cancer Research

Their work has been published frequently in journals such as PLoS ONE, Cancer Research, Oncotarget, Advanced Healthcare Materials, and European Journal of Cancer. In particular, PLoS ONE and Cancer Research account for multiple publications in their portfolio.

Best Publications

  • Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

    Jason I Herschkowitz;Karl Simin;Victor J Weigman;Igor Mikaelian

  • An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation.

    Emma T Bowden;Mara Barth;Dianne Thomas;Robert I Glazer

  • 3D Bioprinting a Cell-laden Bone Matrix for Breast Cancer Metastasis Study

    Xuan Zhou;Wei Zhu;Margaret Nowicki;Shida Miao

  • Modulation of Transcription Factor Sp1 by cAMP-dependent Protein Kinase

    Christian Rohlff;Shakeel Ahmad;Flavia Borellini;Jun Lei

  • Akt1 Induces Extracellular Matrix Invasion and Matrix Metalloproteinase-2 Activity in Mouse Mammary Epithelial Cells

    Bae-Keun Park;Xiao Zeng;Robert I. Glazer

  • Role of AKT1 in 17β-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells

    Shakeel Ahmad;Nadia Singh;Robert I. Glazer

  • 3D printed nanocomposite matrix for the study of breast cancer bone metastasis.

    Wei Zhu;Benjamin Holmes;Robert I. Glazer;Lijie Grace Zhang

  • Induction of Sp1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erythroleukemia cell line TF-1

    F Borellini;R I Glazer

  • Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-β-d-ribofuranosylthiazole-4-carboxamide NSC 286193)

    Hiremagalur N. Jayaram;Robert L. Dion;Robert I. Glazer;David G. Johns

  • Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein.

    Gang Yu;Shakeel Ahmad;Angelo Aquino;Craig R. Fairchild

  • Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways.

    Xiao Yang Wang;Yuzhi Yin;Hongyan Yuan;Toshiyuki Sakamaki

  • Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival

    Xiao-Yang Wang;Xiao-Yang Wang;Hongyan Yuan;R Ilona Linnoila

  • Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.

    T Yazaki;S Ahmad;A Chahlavi;E Zylber-Katz

  • Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells.

    Aquilur Rahman;Syed R. Husain;Javed Siddiqui;Madhu Verma

  • Peroxisome Proliferator-Activated Receptor δ and γ Agonists Differentially Alter Tumor Differentiation and Progression during Mammary Carcinogenesis

    Yuzhi Yin;Robert G. Russell;Luis E. Dettin;Renkui Bai

  • Delayed mammary gland involution in MMTV-AKT1 transgenic mice.

    Scott Ackler;Shakeel Ahmad;Christopher Tobias;Michael D Johnson

  • Phospholipid- and Ca2+-dependent protein kinase activity and protein phosphorylation patterns in the differentiation of human promyelocytic leukemia cell line HL-60

    Ester Zylber-Katz;Robert I. Glazer

  • Peroxisome Proliferator-activated Receptor Modulators As Potential Chemopreventive Agents

    Levy Kopelovich;Judith R. Fay;Robert I. Glazer;James A. Crowell

  • Transformation of Mammary Epithelial Cells by 3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) Is Associated with the Induction of Protein Kinase Cα

    Xiao Zeng;Hangmin Xu;Robert I Glazer

  • Expression of the antisense cDNA for protein kinase C alpha attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells.

    Shakeel Ahmad;R. I. Glazer

Frequent Co-Authors

Levy Kopelovich
Levy Kopelovich Cornell University
Lijie Grace Zhang
Lijie Grace Zhang George Washington University
Thomas E. Smithgall
Thomas E. Smithgall University of Pittsburgh
Chris Albanese
Chris Albanese Georgetown University Medical Center
Alan P. Kozikowski
Alan P. Kozikowski StarWise Therapeutics LLC
David I. Bernstein
David I. Bernstein University of Cincinnati
Hideyuki Okano
Hideyuki Okano Keio University
Victor E. Marquez
Victor E. Marquez National Institutes of Health
Dawei Ma
Dawei Ma Chinese Academy of Sciences
Nicholas M. Dean
Nicholas M. Dean Ionis Pharmaceuticals (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry not only opens doors to research and laboratory roles but also to in-demand careers in healthcare information. Many students leverage science backgrounds to pursue positions like medical coder or health information specialist.

Online degrees in health information management (HIM) are increasingly popular, offering flexible and affordable pathways. Discover him degree online options to start your journey in this dynamic field.

Medical coding and billing are critical components of healthcare administration. For those interested, learn how to become a coder, including training and medical.coder salary expectations. The industry continues to see strong demand, making it a stable choice—see "is medical billing and coding in demand?" for key insights.

Finally, understanding certifications is vital. Compare credentials with this guide to certified coding specialist differences, costs, and career prospects. These pathways can complement Biology and Biochemistry studies, expanding your options in the healthcare sector.

Best Scientists Citing Robert I. Glazer

Trending Scientists

Recently Published Articles